Literature DB >> 27838146

Consensus opinion on MRI simulation for external beam radiation treatment planning.

Eric S Paulson1, Sjoerd P M Crijns2, Brian M Keller3, Jihong Wang4, Maria A Schmidt5, Glyn Coutts6, Uulke A van der Heide7.   

Abstract

AIM: To determine the levels at which consensus could be reached regarding general and site-specific principles of MRI simulation for offline MRI-aided external beam radiation treatment planning.
METHODS: A process inspired by the Delphi method was employed to determine levels of consensus using a series of questionnaires interspersed with controlled opinion feedback.
RESULTS: In general, full consensus was reached regarding general principles of MRI simulation. However, the level of consensus decreased when site-specific principles of MRI simulation were considered.
CONCLUSIONS: These results indicate variability in MRI simulation approaches that are largely explained by the use of MRI in combination with CT. Copyright Â
© 2016 Elsevier Ireland Ltd. All rights reserved.

Keywords:  MR sim; MR simulation; MRI treatment planning

Mesh:

Year:  2016        PMID: 27838146     DOI: 10.1016/j.radonc.2016.09.018

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  19 in total

Review 1.  The future of image-guided radiotherapy will be MR guided.

Authors:  Julianne M Pollard; Zhifei Wen; Ramaswamy Sadagopan; Jihong Wang; Geoffrey S Ibbott
Journal:  Br J Radiol       Date:  2017-03-29       Impact factor: 3.039

2.  Large field of view distortion assessment in a low-field MR-linac.

Authors:  Siamak P Nejad-Davarani; Joshua P Kim; Dongsu Du; Carri Glide-Hurst
Journal:  Med Phys       Date:  2019-03-23       Impact factor: 4.071

Review 3.  Emerging role of MRI in radiation therapy.

Authors:  Hersh Chandarana; Hesheng Wang; R H N Tijssen; Indra J Das
Journal:  J Magn Reson Imaging       Date:  2018-09-08       Impact factor: 4.813

4.  Comparison of radiographer interobserver image registration variability using cone beam CT and MR for cervix radiotherapy.

Authors:  John Rodgers; Rosie Hales; Lee Whiteside; Jacqui Parker; Louise McHugh; Anthea Cree; Marcel van Herk; Ananya Choudhury; Peter Hoskin; Alan McWilliam; Cynthia L Eccles
Journal:  Br J Radiol       Date:  2020-06-16       Impact factor: 3.039

5.  3D T1-weighted turbo spin echo contrast-enhanced MRI at 1.5 T for frameless brain metastases radiotherapy.

Authors:  Jing Yuan; Stephen C K Law; Ka Kin Wong; Gladys G Lo; Michael K M Kam; Wing Hong Kwan; Cindy Xue; Oi Lei Wong; Siu Ki Yu; Kin Yin Cheung
Journal:  J Cancer Res Clin Oncol       Date:  2021-08-06       Impact factor: 4.553

Review 6.  A narrative review of MRI acquisition for MR-guided-radiotherapy in prostate cancer.

Authors:  Jing Yuan; Darren M C Poon; Gladys Lo; Oi Lei Wong; Kin Yin Cheung; Siu Ki Yu
Journal:  Quant Imaging Med Surg       Date:  2022-02

7.  Dosimetric evaluation of magnetic resonance-generated synthetic CT for radiation treatment of rectal cancer.

Authors:  Hesheng Wang; Kevin Du; Juliet Qu; Hersh Chandarana; Indra J Das
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

8.  Dosimetric evaluation of synthetic CT for magnetic resonance-only based radiotherapy planning of lung cancer.

Authors:  Hesheng Wang; Hersh Chandarana; Kai Tobias Block; Thomas Vahle; Matthias Fenchel; Indra J Das
Journal:  Radiat Oncol       Date:  2017-06-26       Impact factor: 3.481

9.  Future mainstream platform for online adaptive radiotherapy will be using on-board MR rather than on-board (CB) CT images.

Authors:  Daniel E Hyer; Bin Cai; Yi Rong
Journal:  J Appl Clin Med Phys       Date:  2021-07-18       Impact factor: 2.102

10.  Assessment of image quality of a radiotherapy-specific hardware solution for PET/MRI in head and neck cancer patients.

Authors:  René M Winter; Sara Leibfarth; Holger Schmidt; Kerstin Zwirner; David Mönnich; Stefan Welz; Nina F Schwenzer; Christian la Fougère; Konstantin Nikolaou; Sergios Gatidis; Daniel Zips; Daniela Thorwarth
Journal:  Radiother Oncol       Date:  2018-05-07       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.